KEVIN KNACK: Open Payments
NPI 1376852772 · MILL VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,064 in 58 payments from 7 companies in 2025. Trend: 2023 $275 · 2024 $406 · 2025 $1,064
Food & beverage: $1,056Education: $8
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 24 | $380 |
| Otsuka America Pharmaceutical, Inc. | 11 | $201 |
| ABBVIE INC. | 9 | $193 |
| E.R. Squibb & Sons, L.L.C. | 8 | $140 |
| Axsome Therapeutics, Inc. | 2 | $62 |
| Janssen Pharmaceuticals, Inc | 2 | $56 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
Products named: ARISTADA, VRAYLAR, COBENFY, REXULTI, ABILIFY MAINTENA, Auvelity, INVEGA SUSTENNA, INGREZZA.
Industry payments across CA — which companies pay providers there.
